Chargement en cours...
An Update on Pharmacotherapy for Leishmaniasis
INTRODUCTION: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL). The treatment of leishmaniasis is challenging and the armamentarium of drugs is small, duration of treatment is long, and most drugs are toxic. AREAS COVE...
Enregistré dans:
| Publié dans: | Expert Opin Pharmacother |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293334/ https://ncbi.nlm.nih.gov/pubmed/25346016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2015.973850 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|